Although Hodgkin’s lymphoma is characterized by genetically driven PD-L1 and PD-L2 overexpression and an inflammatory response, evidence for a tumor antigen-specific response has not yet been described. This evidence concerns the gene PDCD1LG2 and Hodgkins lymphoma.